相关实验视频
Updated: Jul 18, 2026
09:46
Accessing the Cytotoxicity and Cell Response to Biomaterials
Published on: July 8, 2021
3.9K
SMURF1通过调节PKG2表达方式,影响糖尿病患者的牙植入物整合
Xue-Qin Wei1, Sheng-Zhi Zhang2
1Department of Stomatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. XueQinWei12@163.com.
Applied biochemistry and biotechnology
|July 19, 2025
概括
在II型糖尿病 (T2DM) 中,SMAD特异性E3乌比基因蛋白联酶1 (SMURF1) 通过ubiquitination增加和减少2型蛋白激酶 (PKG2). 这会损害牙植入物骨的整合.
科学领域:
- 生物材料科学 生物材料科学
- 细胞生物学 细胞生物学
- 内分泌学 在内分泌学.
背景情况:
- 二型糖尿病 (T2DM) 与牙科植入物结果不佳有关,影响患者的生活质量.
- 蛋白激酶2型 (PKG2) 在骨质分化中发挥作用,对于植入成功至关重要.
研究的目的:
- 调查SMAD特定E3乌比基蛋白联酶1 (SMURF1) 在T2DM中牙植入物骨质整合中的作用.
- 阐明SMURF1通过ubiquitination影响PKG2和骨质生成分化的机制.
主要方法:
- 已建立的T2DM大鼠和高葡萄糖诱导的骨髓介质干细胞 (BMSC) 模型.
- 评估骨质分化,葡萄糖/胰岛素水平和炎症.
- 使用PCR和西欧涂料测量PKG2,SMURF1和内质网膜压力标志物的量化水平.
- 通过共免疫沉分析了SMURF1-PKG2相互作用和PKG2无处不在.
主要成果:
- 在植入后,T2DM大鼠表现出胰岛素耐药性和减少PKG2/Runx2表达.
- 高血糖降低了BMSC骨质分化和PKG2水平,这些水平通过蛋白质酶抑制恢复.
- 在T2DM中升级调节的SMURF1针对PKG2进行无处不在,降低其水平和骨质生成差异化.
- 过度表达PKG2或PKG2激活 (cinaciguat) 逆转了SMURF1诱导的负面影响.
结论:
- 通过SMURF1介导的PKG2无处可见化是损害T2DM骨质生分化的关键机制.
- 准SMURF1或增强PKG2活动可能会改善糖尿病患者的牙植入物骨整合.
相关概念视频
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...